RxDoctor Payments Data

Nancy Gabriel

Family · Rensselaer, NYNPI 1376656322

Payments from drug & device makers

$648in general payments, 2019–2025

Across 22 payments — averaging $29.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$209
  • Medtronic$177
  • Abbott$82
  • Lilly USA, LLC$58
  • GSK$56
  • Pfizer$19
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$648100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca4$209
Medtronic4$177
Abbott4$82
Lilly USA, LLC3$58
GSK3$56
Pfizer1$19
Novo Nordisk1$19
Heartflow, Inc.1$16
AbbVie1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$648 in reported general payments places this provider in the 65th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$12,395
Medicare patients
171
Services billed
194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate25$669
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$304
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$248
Doxycycline Hyclate23$150
Cyclobenzaprine Hcl19$127
Azithromycin20$88
Prednisone31$84

Paid to pharmacies, not to this prescriber.

Other family in Rensselaer

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →